Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Pain|March 20, 2018
Early workplace dialogue in physiotherapy practice improved work ability at 1-year follow-up-WorkUp, a randomised controlled trial in primary careCharlotte P Sennehed, Sara Holmberg, Iben Axén, et al.
Rheumatology (Oxford, England)|February 14, 2009
High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritisBritt-Marie Nyhäll-Wåhlin, Ingemar F Petersson, Jan-Ake Nilsson, et al.
Acta Dermato-Venereologica|December 31, 2015
Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register AnalysisAxel Svedbom, Johan Dahlén, Carla Mamolo, et al.
Nursing & Health Sciences|August 17, 2006
A nurse-led rheumatology clinic's impact on empowering patients with rheumatoid arthritis: A qualitative studyS Barbro Arvidsson, Ann Petersson, Inger Nilsson, et al.
Rheumatology (Oxford, England)|January 24, 2009
Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrsBritta Strömbeck, Lennart T H Jacobsson, Ann Bremander, et al.
The Journal of Rheumatology|August 19, 2010
Cost of illness from the public payers' perspective in patients with ankylosing spondylitis in rheumatological careBritta Strömbeck, Martin Englund, Ann Bremander, et al.
BMC Musculoskeletal Disorders|December 13, 2006
Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritisMaria L E Andersson, Carina A Thorstensson, Ewa M Roos, et al.
Clinical Rheumatology|June 8, 2014
Sociodemographic and disease-related factors are associated with patient-reported anxiety and depression in spondyloarthritis patients in the Swedish SpAScania cohortJorit J L Meesters, Ingemar F Petersson, Stefan Bergman, et al.
JAMA Internal Medicine|July 3, 2013
Biological vs. conventional combination treatment and work loss in early rheumatoid arthritis: a randomized trialJonas K Eriksson, Martin Neovius, Johan Bratt, et al.
The Journal of Rheumatology|July 5, 2005
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritisLennart T H Jacobsson, Carl Turesson, Anders Gülfe, et al.
Pageof 13